Liquidia Technologies

Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using the company's proprietary PRINT? technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The company is focused on the development of two product candidates for which they hold worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension, or PAH, and LIQ865 for the treatment of local post-operative pain.
  • TickerLQDA
  • ISINUS53635D2027
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology

Analysts

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Liana Moussatos ...
  • Shveta Dighe

Restructuring of GSK Partnership Provides Opportunity for Pipeline Expansion

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ValuEngine Rating and Forecast Report for LQDA

ResearchPool Subscriptions

Get the most out of your insights

Get in touch